Tuberculosis (TB) Diagnostics Market Size, Share & Industry Analysis, By Type (Culture-based Diagnostics, Sputum Smear Microscopy, Rapid Molecular Diagnostics, and Others), By End-user (Diagnostics Laboratories and Hospitals), and Regional Forecast, 2026-2034

Last Updated: March 09, 2026 | Format: PDF | Report ID: FBI102009

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Key Industry Developments
2. Incidence of Tuberculosis, By Key Countries
3. Impact of COVID-19 on the Market
Global Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Russia
  6. Nordic
  7. Rest of Europe
Asia Pacific Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. South Korea
  6. Southeast Asia
  7. Rest of Asia Pacific
Latin America Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2026)
2. Company Profiles
  1. F. Hoffmann-La Roche Ltd
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. bioMérieux SA
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. QIAGEN
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. BD
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Cepheid (Danaher)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Abbott Laboratories
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Hologic, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Hain Lifescience GmbH
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Oxford Immunotec USA, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Key Industry Developments
2. Incidence of Tuberculosis, By Key Countries
3. Impact of COVID-19 on the Market
Global Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Russia
  6. Nordic
  7. Rest of Europe
Asia Pacific Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
  2. Japan
  3. India
  4. Australia
  5. South Korea
  6. Southeast Asia
  7. Rest of Asia Pacific
Latin America Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Tuberculosis (TB) Diagnostics Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Culture-based Diagnostics
  2. Sputum Smear Microscopy
  3. Rapid Molecular Diagnostics
  4. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Diagnostic Laboratories
  2. Hospitals
3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2026)
2. Company Profiles
  1. F. Hoffmann-La Roche Ltd
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. bioMérieux SA
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. QIAGEN
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. BD
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Cepheid (Danaher)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Abbott Laboratories
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Hologic, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Hain Lifescience GmbH
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Oxford Immunotec USA, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Tuberculosis (TB) Diagnostics Market Revenue Breakdown (USD Billion, %) by Region, 2026 & 2034

Figure 2: Global Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2026 & 2034

Figure 3: Global Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2026 & 2034

Figure 4: Global Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Region, 2026 & 2034

Figure 5: North America Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Type, 2026 & 2034

Figure 6: North America Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2026

Figure 7: North America Tuberculosis (TB) Diagnostics Market Value (USD Billion), by End-user, 2026 & 2034

Figure 8: North America Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2026

Figure 9: North America Tuberculosis (TB) Diagnostics Market Value (USD Billion), By Country, 2026 & 2034

Figure 10: North America Tuberculosis (TB) Diagnostics Market Value Share (%), By Country, 2026

Figure 11: Europe Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Type, 2026 & 2034

Figure 12: Europe Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2026

Figure 13: Europe Tuberculosis (TB) Diagnostics Market Value (USD Billion), by End-user, 2026 & 2034

Figure 14: Europe Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2026

Figure 15: Europe Tuberculosis (TB) Diagnostics Market Value (USD Billion), By Country/ Sub-region, 2026 & 2034

Figure 16: Europe Tuberculosis (TB) Diagnostics Market Value Share (%), By Country/ Sub-region, 2026

Figure 17: Asia Pacific Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Type, 2026 & 2034

Figure 18: Asia Pacific Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2026

Figure 19: Asia Pacific Tuberculosis (TB) Diagnostics Market Value (USD Billion), by End-user, 2026 & 2034

Figure 20: Asia Pacific Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2026

Figure 21: Asia Pacific Tuberculosis (TB) Diagnostics Market Value (USD Billion), By Country/ Sub-region, 2026 & 2034

Figure 22: Asia Pacific Tuberculosis (TB) Diagnostics Market Value Share (%), By Country/ Sub-region, 2026

Figure 23: Latin America Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Type, 2026 & 2034

Figure 24: Latin America Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2026

Figure 25: Latin America Tuberculosis (TB) Diagnostics Market Value (USD Billion), by End-user, 2026 & 2034

Figure 26: Latin America Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2026

Figure 27: Latin America Tuberculosis (TB) Diagnostics Market Value (USD Billion), By Country/ Sub-region, 2026 & 2034

Figure 28: Latin America Tuberculosis (TB) Diagnostics Market Value Share (%), By Country/ Sub-region, 2026

Figure 29: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value (USD Billion), by Type, 2026 & 2034

Figure 30: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value Share (%), by Type, 2026

Figure 31: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value (USD Billion), by End-user, 2026 & 2034

Figure 32: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value Share (%), by End-user, 2026

Figure 33: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value (USD Billion), By Country/ Sub-region, 2026 & 2034

Figure 34: Middle East & Africa Tuberculosis (TB) Diagnostics Market Value Share (%), By Country/ Sub-region, 2026

Figure 35: Global Tuberculosis (TB) Diagnostics Market Share (%), By Company, 2026

List of Tables

Table 1: Global Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2021-2034

Table 2: Global Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2021-2034

Table 3: Global Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Region, 2021-2034

Table 4: North America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2021-2034

Table 5: North America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2021-2034

Table 6: North America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, By Country, 2021-2034

Table 7: Europe Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2021-2034

Table 8: Europe Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2021-2034

Table 9: Europe Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 10: Asia Pacific Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2021-2034

Table 11: Asia Pacific Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2021-2034

Table 12: Asia Pacific Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 13: Latin America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2021-2034

Table 14: Latin America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2021-2034

Table 15: Latin America Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

Table 16: Middle East & Africa Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by Type, 2021-2034

Table 17: Middle East & Africa Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, by End-user, 2021-2034

Table 18: Middle East & Africa Tuberculosis (TB) Diagnostics Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 121

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com